Chinese Scientist Sun Fanglin, Key Figure in Cancer Research, Dies at 58

Sun Fanglin, a prominent Chinese scientist whose research on cellular aging and tumor formation contributed to the development of new cancer treatments, has died at the age of 58. He passed away on July 10 after receiving treatment for an undisclosed illness, according to an obituary posted by the Advanced Institute of Translational Medicine at Tongji University in Shanghai, where he served as director. Sun was also the former dean of the university's School of Life Sciences and Technology. Sun's work focused on understanding how cells age and how that process can lead to tumors. His findings helped pave the way for new therapies targeting cancer. Colleagues described him as a dedicated researcher who advanced the field of translational medicine, which aims to turn laboratory discoveries into practical treatments for patients. Born in 1966, Sun earned his PhD in biology and spent years studying the molecular mechanisms of aging. He published numerous papers and mentored many young scientists. His death is a loss to the scientific community, particularly in cancer research. The cause of his illness was not disclosed. He is survived by his family.